Oeneo SA (SBT)
Euronext Paris · France · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 8.720 |
|---|---|
| 52-week range | 8.260 – 9.480 |
| Return, 1 month / 3 months | +0.3% / +1.7% |
| Return, 1 year / 3 years | −2.1% / −25.0% |
| Trend | Below its 200-day average |
| RSI (14) | 45 |
| Volatility (1 year) | 19.5% |
| Worst drawdown (1 year) | -12.7% |
| Average daily value traded | 0.03M EUR |
| Dividend yield | 4.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Oeneo is a French company with two main activities serving the wine and spirits industry. Through its cooperages, it makes oak barrels for wineries and distilleries that age their products in wood. Its closures business supplies cork-based stoppers, including treated cork products, to wine producers who bottle their wines for sale. The company is based in France and sells to customers in winegrowing regions around the world.
The shares are listed on the Euronext Paris in France under the code SBT, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Oeneo SA (SBT) trades on the Euronext Paris in France. It last closed at EUR 8.720 on 23 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 83 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 2.1% and over the last three months it rose 1.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 76 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -0.9% | ||
| From 52-week high | -8.0% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.7% | ||
| 6-month return | -1.4% | ||
| 12-month return, skipping the last month | -2.4% | ||
| Stability (higher is calmer) | 93 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 19.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -12.7% | ||
| Liquidity | 48 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.0% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −3.3% |
|---|---|
| 1 month | +0.3% |
| 3 months | +1.7% |
| 6 months | −1.4% |
| 1 year | −2.1% |
| 3 years | −25.0% |
| 5 years | −24.3% |
Signals
| 50-day / 200-day average | 8.849 / 8.802 |
|---|---|
| Golden / death cross (60 days) | Golden, 30 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.146 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Sep 2026 | EUR 0.3500 |
| 1 Oct 2025 | EUR 0.3500 |
| 1 Oct 2024 | EUR 0.3500 |
| 3 Oct 2023 | EUR 0.3500 |
| 3 Oct 2022 | EUR 0.3000 |
| 5 Oct 2021 | EUR 0.2000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.